Market Overview:
The global skin cancer market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of skin cancer, rising awareness about the disease, and technological advancements in diagnosis and treatment of skin cancer. Based on type, the global skin cancer market is segmented into cell carcinoma, squamous-cell carcinoma, melanoma, and others. The cell carcinoma segment accounted for the largest share of the global skin cancer market in 2017 owing to its high prevalence across all regions. Based on application, the global skin cancer market is divided into hospital and clinics, diagnostic centers, and Cancer Research Institute (CRI).
Product Definition:
Skin cancer is the most common form of cancer in the United States. It occurs when abnormal cells in the skin grow out of control.
Cell carcinoma:
Carcinoma is a malignant tumor of cells in the body. Cell carcinoma refers to uncontrolled growth of cells in any part of the body. Carcinomas can occur anywhere but most commonly develop on the skin or in internal organs such as liver, kidney, lungs, and brain. Cell carcinomas are also known as tumors; they are not an essential disease but rather a group of diseases with varied causes and symptoms.
Squamous-cell Carcinoma:
Squamous-cell carcinoma is a type of skin cancer that develops from the squamous cells located in the epidermis. These cells are also known as flat or disc-shaped cells and can be found in adults as well as children. The growth of these tumors can be detected by visual inspection, however, at times it may not be possible to identify since they are very small and have similar characteristics to other skin lesions.
Application Insights:
Skin cancer is categorized based on the application into hospital and clinics, diagnostic centers, and cancer research institutes. The hospital and clinics segment dominated the market in 2017 owing to availability of advanced treatment facilities at major cities across the globe. For instance, Skin Cancer Foundation¢â‚¬â„¢s sun safety education program offered through dermatology offices has helped more than 20 million people worldwide since its inception in 1998.
The demand for skin cancer diagnosis is increasing due to rising prevalence of risk factors such as UV radiation exposure from sunlight or artificial sources coupled with genetic mutations that increase susceptibility towards malignant skin tumors. According to a study published by NCBI in 2018, it was estimated that around 1% of total population of Europe are susceptible towards melanoma while 3% are likely to get some form of skin tumor like keratinocyte carcinoma or basal cell carcinoma during their lifetime if they do not take any preventive measures against UV rays.
Regional Analysis:
North America dominated the global skin cancer market in 2017. This can be attributed to the high incidence rate of skin cancer, increasing awareness about early detection and treatment, presence of well-established healthcare facilities in this region, and availability of highly skilled dermatologists & surgeons. In addition, rising number of research studies on various types of skin cancers is expected to fuel the growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rise in disposable income coupled with growing population base especially in China & India which accounts for majority share due to higher birth rate as compared to death rate resulting into more people living at present than future leading into greater demand for medical products such as diagnosis tools used for early detection or treatment methods that would spare patient from any kind of surgery thus driving market growth during forecast period. Moreover, increase government spending on healthcare sector along with favorable reimbursement policies are some other factors contributing toward regional market development (Babcock 2018).
Growth Factors:
- Increasing awareness about skin cancer and its prevention among people.
- Growing incidence of skin cancer due to changing lifestyle and increasing exposure to the sun's UV radiation.
- Rising demand for minimally invasive diagnostic and treatment procedures for skin cancer patients.
- Technological advancements in diagnosis and treatment of skin cancer leading to better outcomes for patients.
- increasing number of research studies on the epidemiology, pathogenesis, diagnosis, and treatment of skin cancers
Scope Of The Report
Report Attributes
Report Details
Report Title
Skin Cancer Market Research Report
By Type
Cell carcinoma, Squamous-cell Carcinoma, Melanoma, Others
By Application
Hospital and Clinics, Diagnostic Centers, Cancer Research Institute
By Companies
Roche, Novartis, Sun Pharma, Elekta, Varian Medical Systems, Cannabis Science, Cellceutix, LEO Pharma, Moberg Pharma, Mylan, Eli Lilly, Bristol Myers Squibb, Boehringer Ingelheim, Aqua Pharmaceuticals, Bausch Health, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Skin Cancer Market Report Segments:
The global Skin Cancer market is segmented on the basis of:
Types
Cell carcinoma, Squamous-cell Carcinoma, Melanoma, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital and Clinics, Diagnostic Centers, Cancer Research Institute
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Novartis
- Sun Pharma
- Elekta
- Varian Medical Systems
- Cannabis Science
- Cellceutix
- LEO Pharma
- Moberg Pharma
- Mylan
- Eli Lilly
- Bristol Myers Squibb
- Boehringer Ingelheim
- Aqua Pharmaceuticals
- Bausch Health
- Merck
Highlights of The Skin Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell carcinoma
- Squamous-cell Carcinoma
- Melanoma
- Others
- By Application:
- Hospital and Clinics
- Diagnostic Centers
- Cancer Research Institute
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Skin Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Skin cancer is a type of cancer that develops when cells in the skin grow out of control. The most common types of skin cancer are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. Skin cancers can occur anywhere on the body, but are most commonly found on the face, neck, and hands.
Some of the major companies in the skin cancer market are Roche, Novartis, Sun Pharma, Elekta, Varian Medical Systems, Cannabis Science, Cellceutix, LEO Pharma, Moberg Pharma, Mylan, Eli Lilly, Bristol Myers Squibb, Boehringer Ingelheim, Aqua Pharmaceuticals, Bausch Health, Merck.
The skin cancer market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Skin Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Skin Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Skin Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Skin Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Skin Cancer Market Size & Forecast, 2018-2028
4.5.1 Skin Cancer Market Size and Y-o-Y Growth
4.5.2 Skin Cancer Market Absolute $ Opportunity
Chapter 5 Global Skin Cancer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Skin Cancer Market Size Forecast by Type
5.2.1 Cell carcinoma
5.2.2 Squamous-cell Carcinoma
5.2.3 Melanoma
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Skin Cancer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Skin Cancer Market Size Forecast by Applications
6.2.1 Hospital and Clinics
6.2.2 Diagnostic Centers
6.2.3 Cancer Research Institute
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Skin Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Skin Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Skin Cancer Analysis and Forecast
9.1 Introduction
9.2 North America Skin Cancer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Skin Cancer Market Size Forecast by Type
9.6.1 Cell carcinoma
9.6.2 Squamous-cell Carcinoma
9.6.3 Melanoma
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Skin Cancer Market Size Forecast by Applications
9.10.1 Hospital and Clinics
9.10.2 Diagnostic Centers
9.10.3 Cancer Research Institute
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Skin Cancer Analysis and Forecast
10.1 Introduction
10.2 Europe Skin Cancer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Skin Cancer Market Size Forecast by Type
10.6.1 Cell carcinoma
10.6.2 Squamous-cell Carcinoma
10.6.3 Melanoma
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Skin Cancer Market Size Forecast by Applications
10.10.1 Hospital and Clinics
10.10.2 Diagnostic Centers
10.10.3 Cancer Research Institute
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Skin Cancer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Skin Cancer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Skin Cancer Market Size Forecast by Type
11.6.1 Cell carcinoma
11.6.2 Squamous-cell Carcinoma
11.6.3 Melanoma
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Skin Cancer Market Size Forecast by Applications
11.10.1 Hospital and Clinics
11.10.2 Diagnostic Centers
11.10.3 Cancer Research Institute
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Skin Cancer Analysis and Forecast
12.1 Introduction
12.2 Latin America Skin Cancer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Skin Cancer Market Size Forecast by Type
12.6.1 Cell carcinoma
12.6.2 Squamous-cell Carcinoma
12.6.3 Melanoma
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Skin Cancer Market Size Forecast by Applications
12.10.1 Hospital and Clinics
12.10.2 Diagnostic Centers
12.10.3 Cancer Research Institute
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Skin Cancer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Skin Cancer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Skin Cancer Market Size Forecast by Type
13.6.1 Cell carcinoma
13.6.2 Squamous-cell Carcinoma
13.6.3 Melanoma
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Skin Cancer Market Size Forecast by Applications
13.10.1 Hospital and Clinics
13.10.2 Diagnostic Centers
13.10.3 Cancer Research Institute
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Skin Cancer Market: Competitive Dashboard
14.2 Global Skin Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Novartis
14.3.3 Sun Pharma
14.3.4 Elekta
14.3.5 Varian Medical Systems
14.3.6 Cannabis Science
14.3.7 Cellceutix
14.3.8 LEO Pharma
14.3.9 Moberg Pharma
14.3.10 Mylan
14.3.11 Eli Lilly
14.3.12 Bristol Myers Squibb
14.3.13 Boehringer Ingelheim
14.3.14 Aqua Pharmaceuticals
14.3.15 Bausch Health
14.3.16 Merck
